Virus in Biological Technology

Microbix Sales Grow 22% For Nine Months

... been in the news since the emergence of the H1N1 virus in April, a virus that met the WHO criteria of a pandemic strain," ... 25 to 50% of the yields obtained for seasonal virus strains. Several large global influenza vaccine ...

GeoVax Labs, Inc. Provides Clinical Studies Update

... trials conducted using a simian immunodeficiency virus (SIV) prototype of the GeoVax HIV vaccine in ... antibody response against the natural form of the virus envelope glycoprotein as well as protective T ... Immunodeficiency Disease (AIDS), caused by the virus known as HIV-1, should the person ever become ...

Eiger BioPharmaceuticals Acquires Exclusive License to Novel Hepatitis C Virus (HCV) Technology From Stanford University

... exclusive worldwide rights to novel Hepatitis C virus (HCV) technology from Stanford University. This ... of antiviral therapy," said Jeffrey Glenn. "These virus specific agents in development at Eiger possess ... for HCV therapy." About Hepatitis C virus Infections from HCV have reached pandemic ...

Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients

... SOC. Patients who achieve undetectable levels of virus at weeks 4 and 12 will be randomized to stop all ... is the proportion of patients with undetectable virus at week 12 (defined as c omplete E arly V ... as the proportion of patients with undetectable virus at week 4 (defined as R apid V irological R ...

Medicago's H1N1 pandemic vaccine candidate shows positive response in 100% of vaccinated animals after a single dose

... response against a new emerging strain of this virus in 100% of vaccinated animals. Medicago's H1N1 ... protect against the influenza A/California/04/09 virus ("California/04"), which was one of the original ... using its VLP technology that does not require a virus and therefore does not rely on the ability of a ...

ImmuneRegen BioSciences Confirms Homspera's Therapeutic Anti-Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Administration

... effects against the current pandemic H1N1 virus infection. Preliminary analysis of ongoing ... on these findings, the Company commissioned H1N1 virus studies to be performed in the laboratories of a ... Using the accepted ferret model of H1N1 influenza virus infection, animals were treated orally ...

FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business

... its test for detecting the 2009 H1N1 influenza virus (the "pandemic flu virus"), a strain of influenza A virus initially referred to as the swine flu virus. ... to qualitatively detect RNA of the pandemic flu virus in a patient's nasal or nasopharyngeal specimens. ...

Novavax Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies

... today final selection of a Respiratory Syncytial virus (RSV) vaccine candidate that will be advanced ... "fusion" protein, which is the protein that the virus uses to infect and fuse with cells in the ... disease." ABOUT RESPIRATORY SYNCYTIAL virus RSV is the most commonly identified cause of ...

MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus

... central nervous system infection due to West Nile virus (WNV). MacroGenics, a privately held ... treatments for individuals with severe West Nile virus infection. These patients are hospitalized and ... care. Therefore, a therapy that neutralizes the virus and could possibly reduce or prevent ...

CEL-SCI Corporation Releases Letter to Shareholders

... person infected with a combined bird/swine flu virus gets on a plane, there will be no way to contain ... likely be this fall and winter, even without the virus getting worse. In the United Kingdom, the ... promotes resortment. A further-mutated swine flu virus that combines with the bird flu in Egypt or ...

CEL-SCI Files Patent Application to Support Company's Treatment for More Virulent Strain of H1N1 Swine and Other Influenza Viruses

... believe that by the next flu season the swine flu virus will have evolved and/or combined with other ... flu pandemic. CEL-SCI's efforts to fight this virus are focused on using conserved epitopes from essential proteins to be found in the A influenza virus for H1N1, H1N5, swine, bird flu and Spanish ...

Sinovac Completes Construction of H1N1 Virus Seed Bank

... that it has completed construction of the H1N1 virus seed bank necessary to produce a virus antigen. Sinovac received the seed virus from the US Center for Disease Control (CDC) on ...

Australia: Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight

... first medical face mask to kill the Influenza A virus within seconds of contact while retaining the ... Containment is critical. The Influenza A virus can stay alive on hands and surfaces for hours ... was sprayed with live aerosolized Influenza A virus equivalent to approximately 1,000 times ...

Lethality of H1N1 Influenza Virus Increasing According to Latest Analysis of Virus Peptide Genomic Data

... peptide genomic data for the H1N1 influenza virus indicates that the current global outbreak of ... the Lethality Gene in 836 previous H1N1 influenza virus isolates has remained essentially unchanged (at ... software, the firm predicted the current H1N1 virus outbreak, and last month (5/23/09) an increase in ...

Sinovac Begins the Production of Influenza A (H1N1) Vaccine

... the H1N1 virus. Today, Sinovac has received the virus seed, we will start the production of H1N1 vaccine immediately from production of virus seed lots. Throughout this critical time, Sinovac ... for H1N1 will depend on the performance of the virus seed. In order to supply enough vaccines ...

Mach One Corporation Developing a Nasal, Hand Carried Product as Solution to Swine Flu (H1N1) Virus

... Create A Barrier To Block The Attachment Of The virus To The Nasal Membranes BELGIUM, Wis., June 4 ... mechanical barrier to block the attachment of the virus to the nasal membranes. Peter Nash, Ph.D. ... said, "Having worked with the influenza virus group since 1974, the current strain of influenza ...

Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus

... are nearly identical to those of the novel H1N1 virus but the VLPs are not infectious as they lack the ... to public health." The influenza A (H1N1) virus was first detected in April 2009, in Mexico, the ... vaccines is important to reduce the spread of the virus and to potentially prevent a pandemic from ...

HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1)

... mist sprayed into the nose, where the influenza virus usually enters the body. It contains live vaccine virus strains that are weakened so as not to cause the ... million doses of seasonal FluMist(R) (Influenza virus Vaccine Live, Intranasal) to health care ...

Sanofi Pasteur Receives Seed Virus to Produce New Influenza A(H1N1) Vaccine

... The emergence of a new influenza A(H1N1) virus strain recently led the World Health Organization ... alert, following human-to-human spread of the virus into at least two countries in one WHO region. ... looks forward to quickly understanding how this virus performs in a vaccine manufacturing environment ...

Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data

... and determined that the infectivity of the H1N1 virus will increase markedly, while its lethality will ... and determined that the infectivity of the H1N1 virus will increase markedly, while its lethality will ... destroy or restrict replication of the targeted virus strains prior to an outbreak." Earlier ...

Pharmasset Reports Fiscal Second Quarter 2009 Financial Results

... expenses for our second generation hepatitis C virus (HCV) product candidate, PSI-7851, and the purine ... therapeutics for the treatment of hepatitis C virus (HCV) and, secondarily, on the development of ... for the treatment of human immunodeficiency virus (HIV). Our research and development efforts focus ...

Novavax Reports First Quarter 2009 Financial Results

... candidate against the novel influenza A (H1N1) virus that has recently emerged in the United States ... recent emergence of the novel influenza A (H1N1) virus highlights the potential value of our recombinant ... candidates against the Respiratory Syncitial virus (RSV); Commencement of operations of the ...

Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate

... to produce antibodies that neutralize influenza virus and prevent spread throughout the cells of the respiratory tract -- and the matrix 1 or "M1" virus that stimulates cytotoxic T lymphocytes to kill ... M1. Further, the VLPs are not made from a live virus and have no genetic material in their inner core, ...

First H1N1 Swine Flu Vaccine, Replikins-Based, Is Ready Now for Testing Worldwide

... vaccines based on, key sub-sequences of the virus genome that are critical to its rapid ... technology, which examines specific regions in virus genes that have been linked with past epidemics. ... two different host populations: the lethal Taura virus in shrimp populations, and the avian flu (H5N1) ...

H1N1 Influenza "Swine Flu" Peptide Vaccine Now Available For Testing Worldwide

... technology, which examines specific regions in virus genes that have been linked with past epidemics. ... two previous viral outbreaks: the lethal Taura virus with shrimp populations and the avian flu (H5N1) ... the University of Georgia and shown to block H5N1 virus entry, replication, and excretion in chickens ...

InterMune Reports First Quarter 2009 Financial Results and Business Highlights

... study of ITMN-191 (R7227) in hepatitis C virus (HCV) patients and shortly thereafter reported ... in the last two dosage cohorts had levels of virus in their blood below the limit of quantification ... 14, and 33% of these patients had no detectable virus in their blood at day 14. Patients ...

Sinovac Initiates Preparatory Activities for Swine Flu Vaccine

... Sinovac expects to receive the swine flu virus strain in the near future, enabling the Company ... vaccine for adults, however, the new flu virus has infected many children this time. In order to ... Swine Flu vaccine prototype specific to the H1N1 virus strain. Once this vaccine strain is available ...

LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record

... pipeline will address Human Immunodeficiency virus (HIV), Hepatitis C virus (HCV), Human Papilloma virus (HPV) and Herpes ...

Biotechnology Company, Replikins Ltd., Provided Advance Warning of Mexican H1N1 'Swine Flu' Virus Outbreak

... technology, which examines specific regions in virus genes which have been linked with past epidemics. ... shown to successfully block the entry of H5N1 virus into, replication in, and excretion from ... of H1N1 outbreaks: --- H1N1 Influenza virus with Highest Replikin Count(TM) Since the 1918 ...

Biotechnology Company Provided Advance Warning of Mexican H1N1 "Swine Flu" Virus Outbreak

... technology, which examines specific regions in virus genes which have been linked with past ... technology, which examines specific regions in virus genes which have been linked with past ... technology, which examines specific regions in virus genes which have been linked with past ...

NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains

... highly pathogenic avian influenza subtype H5N1 virus strain, isolated from a fatal human case in 2004 ... 1 (M1) proteins from 1918 Spanish influenza virus strains. These proteins, which were produced in ... structures that mimic the 1918 pandemic influenza virus but without the genetic material needed for ...

Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India

... of an adjuvant by using a structure similar to a virus but without the genetic material required for ... a more robust immune response. In addition, live virus is not needed to produce a VLP vaccine. Rather, ... scientists need only the genetic sequence of a virus to quickly create a VLP vaccine against it. ...

Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates

... pre-treatment viral load of 22,868,000 HCV virus copies/ml blood (cpm) was reduced on average by ... Hospital in Delhi, India. About Hepatitis-C virus HCV is a leading cause of chronic liver ... to inhibit disease progression of Hepatitis-C virus (HCV) and Human ...

Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections

... its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models. ... clinical trials for the treatment of hepatitis C virus (HCV) infection and in preclinical development ... a property of the host cell rather than the virus itself, anti-PS antibodies have the potential to ...

Confirmation of Bogoch Replikins Influenza Patents by Harvard-CDC and Scripps-Crucell Data

... points between the neutralizing antibody and the virus that the Harvard-CDC and Scripps-Crucell ... Recognition of a Highly Conserved Influenza virus Epitope." Science DOI: 10.1126-science.1171491, ... Year by Replikins' FluForecast(R) Quantitative virus Analysis; June 8, 2007). REPLIKINS, Ltd., 38 ...

InterMune to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting

... research programs related to the hepatitis C virus (HCV) have been accepted for presentation at the ... Ribavirin in Patients with Chronic Hepatitis C virus (HCV). Incidence of Virologic Escape ... Model with Long Term Expression of Hepatitis C virus NS3/4A Protease for the Pharmacokinetic and ...

GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results

... vaccination in simian immunodeficiency virus (SIV) infected non-human primates with the ... levels. The excellent control of the virus infection in the absence of drug treatment was ... vaccination will be to "control" HIV virus levels in infected individuals to very low ...

AcroMetrix Announces the Release of OptiQuant-S Hepatitis C Virus (HCV) Panel

... routinely monitored for changes in the amount of virus (i.e. viral load) present in the patient when ... of synthetic sequences into a mammalian RNA virus which were shown to be stable in replication and capable of forming infectious RNase resistant virus particles. This new proprietary system can be ...

NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate Directed Against the Fusion (F) Protein

... a preclinical study of a Respiratory Syncytial virus ("RSV") vaccine candidate directed against the viral fusion (F) protein. The virus utilizes the F protein to fuse with cells in the ... RSV infection, reducing the quantity of RSV virus found in the lungs of immunized mice after a ...

Romark Announces Presentation of New Data for Controlled Release Nitazoxanide in Chronic Hepatitis C

... in the treatment of chronic hepatitis C virus (HCV) infection. In the phase II study in ... Nitazoxanide is a potent inhibitor of hepatitis C virus (HCV) replication in HCV genotype 1-derived ... shown that it does not induce mutations in the virus that confer resistance. In phase II clinical ...